Patients suffering from rheumatoid arthritis are treated for around six months with the standard anti-rheumatic agent methotrexate, to which many patients respond very well. However, if they do not respond and no remission or at least reduction in the activity of the disease can be achieved, they are given a combined treatment of methotrexate and...
Category: <span>Pharmaceutical Updates</span>
Post
MIRACLE JAB Heart attack ‘vaccine’ available in just SIX years to knock cholesterol busting statins off the shelves
AN injection that lowers cholesterol to protect against heart attacks will be available within six years, doctors hope. The once-a-year jab, now being tested in clinical trials, would end the need to take daily statin pills for millions of patients. It works by boosting the body’s ability to remove cholesterol from the blood, cutting levels...
Post
Breakthrough cystic fibrosis drug that prevents ‘irreversible’ lung damage in children under 12 is hailed by experts
Orkambi helped to improve the diminishing lung function of child sufferers Charities claim the latest findings of the combination medication are exciting Cystic Fibrosis Trust said the drug has the power to ‘prevent irreversible damage’ A drug that targets the underlying cause of cystic fibrosis has been hailed as a ‘major step forward’ by experts....
Post
US Army invests $2million in research to test ‘game changer’ one-shot injection to beat PTSD
A ‘stellate ganglion block’ is an injection of anesthetic into a nerve cluster called the stellate ganglion, which connects the brain to the body This nerve cluster is key for controlling our response to perceived danger Scientists claim one shot to numb this cluster can ‘reset’ our nervous system The injection has been used successfully...
Post
For diabetics, nasal powder fixed severe low blood sugar
(HealthDay)—For many people with diabetes, low blood sugar levels are a serious health risk, but researchers report that a new nasal powder quickly reverses the effects of this dangerous condition. Better yet, it can be administered even when someone is unconscious, the researchers added. The nasal powder contains the hormone glucagon. This hormone tells the...
Post
Traditional Chinese medicine may benefit some heart disease patients
Traditional Chinese medicine might be effective as a complement or alternative to traditional Western medicine for primary and secondary prevention of heart disease, according to a state of the art review paper published today in the Journal of the American College of Cardiology. Heart disease is the No. 1 cause of death worldwide, and despite advances...
Post
Arthritis drug could cure severe heart condition
A drug currently being trialed for the treatment of rheumatoid arthritis has the potential to be the first ever drug to prevent aortic valve stenosis, a common and deadly heart condition that is estimated to affect around 50 percent of elderly adults in the United States. Researchers may have discovered a drug that can prevent...
Post
Lactic acid that makes running agony eases back pain: Injection into discs in the spine may stop nerves getting trapped
Researchers are injecting lactic acid into discs in the spine The theory is that lactic acid plumps up the damaged disc to make it stiffer This means nerves are less likely to get trapped and cause pain Damaged discs are thought to be a major cause of back pain A jab which contains a chemical...
Post
Drug combination benefits patients with tophaceous gout
The drug lesinurad in combination with febuxostat was better at lowering blood levels of urate than febuxostat alone in a phase III clinical trial of 324 patients with tophaceous gout. Over 12 months, significantly more patients in the combination group achieved target levels of urate than patients in the febuxostat group. Gout occurs when urate...
Post
An inexpensive first-line treatment for type 2 diabetes may also reduce heart disease in those with type 1 diabetes
An inexpensive first-line treatment for type 2 diabetes may also reduce heart disease in those with type 1 diabetes, according to a new global trial led by the University of Glasgow. The REMOVAL trial’s results, announced today at the American Diabetes Association’s 77th Scientific Sessions conference in San Diego, and published in the journal The Lancet...